Effects of all-trans-retinoic acid (ATRA) and retinoic acid receptor (RAR) expression on secretion, growth, and apoptosis of insulin-secreting RINm5F cells
To define the functions of retinoids and their receptors in insulin secretion, we tested the effects of all-trans-retinoic acid (ATRA) and retinoic acid receptor (RAR) expression on cell growth, differentiation, and secretion using insulin-secreting RINm5F cells. Wild-type cells with a low abundance...
Gespeichert in:
Veröffentlicht in: | Pancreas 1997-08, Vol.15 (2), p.122-131 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 131 |
---|---|
container_issue | 2 |
container_start_page | 122 |
container_title | Pancreas |
container_volume | 15 |
creator | CHERTOW, B. S GOKING, N. Q DRISCOLL, H. K PRIMERANO, D. A MATTHEWS, K. A |
description | To define the functions of retinoids and their receptors in insulin secretion, we tested the effects of all-trans-retinoic acid (ATRA) and retinoic acid receptor (RAR) expression on cell growth, differentiation, and secretion using insulin-secreting RINm5F cells. Wild-type cells with a low abundance of mRNA for RAR beta were transfected with RAR beta or chloramphenicol acetyltransferase (CAT control). Cells were cultured for 2-7 days in media without (A-def) or with ATRA, 1, 10, 100, and 1,000 nM. At day 2 of culture, ATRA stimulated insulin release in wild-type and transfected cells, and this effect was dose dependent. At 7 days, ATRA stimulated insulin secretion from wild-type cells twofold at glucose concentrations of 0.5 mM (A-def, 5.1 +/- 0.27; ATRA, 1,000 nM, 10.5 +/- 1.43 ng/10(6) cells) and at 11.0 mM (A-def, 6.9 +/- 0.24; ATRA, 1,000 nM, 13.6 +/- 1.86 ng/10(6) cells). The cellular insulin content was increased about threefold (A-def, 39.2 +/- 2.95; ATRA, 1,000 nM, 118 +/- 8.54 ng/10(6) cells). ATRA inhibited growth of wild-type cells as early as 3 days, and this effect was dose dependent. Whereas in the absence of ATRA, the cell number increased over fivefold between day 3 and day 5, ATRA, 1,000 nM, inhibited cell growth completely. ATRA, 1,000 nM, increased apoptotic RINm5F cells (day 3 A-def, 0.53 +/- 0.27% of total cells, and ATRA, 2.30 +/- 1.44; day 5 A-def, 0.38 +/- 0.23, and ATRA, 2.14 +/- 0.59; day 7 A-def, 0.90 +/- 0.29, and ATRA, 6.02 +/- 1.64). RAR beta-transfected cells showed overexpression of mRNA to RAR beta and dose-dependent inhibition of growth, with almost-complete inhibition at ATRA concentrations as low as 100 nM. Overexpression of RAR beta increased insulin secretion at ATRA, 100-1,000 nM. In summary, ATRA increased the insulin secretion and content of RINm5F cells, while inhibiting growth and increasing apoptosis. Increased expression of RAR beta facilitated these effects on growth and secretion. These findings may reflect the known effect of ATRA on differentiation of cells and mediation through RAR beta. |
doi_str_mv | 10.1097/00006676-199708000-00003 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00006676_199708000_00003</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>9260196</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-576d883e06f012e32db0eb412ab9287c871210174c508299085ff65da02641683</originalsourceid><addsrcrecordid>eNpVkNtKAzEURYMotVY_QciDDxYazaW5PZbSaqEolPo8pJmkRqYzQzJF_RZ_1unFgiEQztl7n0MWAJDgB4K1fMTtEUIKRLSWWLUV2rXYGegSzgQaKqrOQRcrxREjUl6Cq5Q-MCaScd0BHU0FJlp0wc_Ee2ebBCsPTVGgJpoyoeiaUFbBQmNDDu9Hy8WoD02Zw_9CdNbVTRXh_WK06EP3VUeXUqhK2N7k7M5dlQO4jtVn8z7YTzB11UZS2G8MZdoWoURHb7mGi9nLhk-hdUWRrsGFN0VyN8e3B96mk-X4Gc1fn2bj0RxZxmSDuBS5Usxh4TGhjtF8hd1qSKhZaaqkVZJQ0v58aDlWVGusuPeC5wZTMSRCsR5Qh7k2VilF57M6ho2J3xnB2Q539oc7O-Het1gbvT1E6-1q4_JT8Mi31e-OuknWFL6la0M62aiUlHPCfgE3uYcn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effects of all-trans-retinoic acid (ATRA) and retinoic acid receptor (RAR) expression on secretion, growth, and apoptosis of insulin-secreting RINm5F cells</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>CHERTOW, B. S ; GOKING, N. Q ; DRISCOLL, H. K ; PRIMERANO, D. A ; MATTHEWS, K. A</creator><creatorcontrib>CHERTOW, B. S ; GOKING, N. Q ; DRISCOLL, H. K ; PRIMERANO, D. A ; MATTHEWS, K. A</creatorcontrib><description>To define the functions of retinoids and their receptors in insulin secretion, we tested the effects of all-trans-retinoic acid (ATRA) and retinoic acid receptor (RAR) expression on cell growth, differentiation, and secretion using insulin-secreting RINm5F cells. Wild-type cells with a low abundance of mRNA for RAR beta were transfected with RAR beta or chloramphenicol acetyltransferase (CAT control). Cells were cultured for 2-7 days in media without (A-def) or with ATRA, 1, 10, 100, and 1,000 nM. At day 2 of culture, ATRA stimulated insulin release in wild-type and transfected cells, and this effect was dose dependent. At 7 days, ATRA stimulated insulin secretion from wild-type cells twofold at glucose concentrations of 0.5 mM (A-def, 5.1 +/- 0.27; ATRA, 1,000 nM, 10.5 +/- 1.43 ng/10(6) cells) and at 11.0 mM (A-def, 6.9 +/- 0.24; ATRA, 1,000 nM, 13.6 +/- 1.86 ng/10(6) cells). The cellular insulin content was increased about threefold (A-def, 39.2 +/- 2.95; ATRA, 1,000 nM, 118 +/- 8.54 ng/10(6) cells). ATRA inhibited growth of wild-type cells as early as 3 days, and this effect was dose dependent. Whereas in the absence of ATRA, the cell number increased over fivefold between day 3 and day 5, ATRA, 1,000 nM, inhibited cell growth completely. ATRA, 1,000 nM, increased apoptotic RINm5F cells (day 3 A-def, 0.53 +/- 0.27% of total cells, and ATRA, 2.30 +/- 1.44; day 5 A-def, 0.38 +/- 0.23, and ATRA, 2.14 +/- 0.59; day 7 A-def, 0.90 +/- 0.29, and ATRA, 6.02 +/- 1.64). RAR beta-transfected cells showed overexpression of mRNA to RAR beta and dose-dependent inhibition of growth, with almost-complete inhibition at ATRA concentrations as low as 100 nM. Overexpression of RAR beta increased insulin secretion at ATRA, 100-1,000 nM. In summary, ATRA increased the insulin secretion and content of RINm5F cells, while inhibiting growth and increasing apoptosis. Increased expression of RAR beta facilitated these effects on growth and secretion. These findings may reflect the known effect of ATRA on differentiation of cells and mediation through RAR beta.</description><identifier>ISSN: 0885-3177</identifier><identifier>EISSN: 1536-4828</identifier><identifier>DOI: 10.1097/00006676-199708000-00003</identifier><identifier>PMID: 9260196</identifier><identifier>CODEN: PANCE4</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Apoptosis - drug effects ; Biological and medical sciences ; Blotting, Northern ; Cell Division - drug effects ; Cell Line ; Deoxyuracil Nucleotides - metabolism ; Diabetes. Impaired glucose tolerance ; DNA Nucleotidylexotransferase - metabolism ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Gene Expression ; Glucose - pharmacology ; Insulin - metabolism ; Insulin Secretion ; Islets of Langerhans - cytology ; Islets of Langerhans - drug effects ; Islets of Langerhans - metabolism ; Medical sciences ; Receptors, Retinoic Acid - genetics ; Receptors, Retinoic Acid - physiology ; Transfection ; Tretinoin - pharmacology</subject><ispartof>Pancreas, 1997-08, Vol.15 (2), p.122-131</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-576d883e06f012e32db0eb412ab9287c871210174c508299085ff65da02641683</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2772551$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9260196$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CHERTOW, B. S</creatorcontrib><creatorcontrib>GOKING, N. Q</creatorcontrib><creatorcontrib>DRISCOLL, H. K</creatorcontrib><creatorcontrib>PRIMERANO, D. A</creatorcontrib><creatorcontrib>MATTHEWS, K. A</creatorcontrib><title>Effects of all-trans-retinoic acid (ATRA) and retinoic acid receptor (RAR) expression on secretion, growth, and apoptosis of insulin-secreting RINm5F cells</title><title>Pancreas</title><addtitle>Pancreas</addtitle><description>To define the functions of retinoids and their receptors in insulin secretion, we tested the effects of all-trans-retinoic acid (ATRA) and retinoic acid receptor (RAR) expression on cell growth, differentiation, and secretion using insulin-secreting RINm5F cells. Wild-type cells with a low abundance of mRNA for RAR beta were transfected with RAR beta or chloramphenicol acetyltransferase (CAT control). Cells were cultured for 2-7 days in media without (A-def) or with ATRA, 1, 10, 100, and 1,000 nM. At day 2 of culture, ATRA stimulated insulin release in wild-type and transfected cells, and this effect was dose dependent. At 7 days, ATRA stimulated insulin secretion from wild-type cells twofold at glucose concentrations of 0.5 mM (A-def, 5.1 +/- 0.27; ATRA, 1,000 nM, 10.5 +/- 1.43 ng/10(6) cells) and at 11.0 mM (A-def, 6.9 +/- 0.24; ATRA, 1,000 nM, 13.6 +/- 1.86 ng/10(6) cells). The cellular insulin content was increased about threefold (A-def, 39.2 +/- 2.95; ATRA, 1,000 nM, 118 +/- 8.54 ng/10(6) cells). ATRA inhibited growth of wild-type cells as early as 3 days, and this effect was dose dependent. Whereas in the absence of ATRA, the cell number increased over fivefold between day 3 and day 5, ATRA, 1,000 nM, inhibited cell growth completely. ATRA, 1,000 nM, increased apoptotic RINm5F cells (day 3 A-def, 0.53 +/- 0.27% of total cells, and ATRA, 2.30 +/- 1.44; day 5 A-def, 0.38 +/- 0.23, and ATRA, 2.14 +/- 0.59; day 7 A-def, 0.90 +/- 0.29, and ATRA, 6.02 +/- 1.64). RAR beta-transfected cells showed overexpression of mRNA to RAR beta and dose-dependent inhibition of growth, with almost-complete inhibition at ATRA concentrations as low as 100 nM. Overexpression of RAR beta increased insulin secretion at ATRA, 100-1,000 nM. In summary, ATRA increased the insulin secretion and content of RINm5F cells, while inhibiting growth and increasing apoptosis. Increased expression of RAR beta facilitated these effects on growth and secretion. These findings may reflect the known effect of ATRA on differentiation of cells and mediation through RAR beta.</description><subject>Apoptosis - drug effects</subject><subject>Biological and medical sciences</subject><subject>Blotting, Northern</subject><subject>Cell Division - drug effects</subject><subject>Cell Line</subject><subject>Deoxyuracil Nucleotides - metabolism</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>DNA Nucleotidylexotransferase - metabolism</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Gene Expression</subject><subject>Glucose - pharmacology</subject><subject>Insulin - metabolism</subject><subject>Insulin Secretion</subject><subject>Islets of Langerhans - cytology</subject><subject>Islets of Langerhans - drug effects</subject><subject>Islets of Langerhans - metabolism</subject><subject>Medical sciences</subject><subject>Receptors, Retinoic Acid - genetics</subject><subject>Receptors, Retinoic Acid - physiology</subject><subject>Transfection</subject><subject>Tretinoin - pharmacology</subject><issn>0885-3177</issn><issn>1536-4828</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkNtKAzEURYMotVY_QciDDxYazaW5PZbSaqEolPo8pJmkRqYzQzJF_RZ_1unFgiEQztl7n0MWAJDgB4K1fMTtEUIKRLSWWLUV2rXYGegSzgQaKqrOQRcrxREjUl6Cq5Q-MCaScd0BHU0FJlp0wc_Ee2ebBCsPTVGgJpoyoeiaUFbBQmNDDu9Hy8WoD02Zw_9CdNbVTRXh_WK06EP3VUeXUqhK2N7k7M5dlQO4jtVn8z7YTzB11UZS2G8MZdoWoURHb7mGi9nLhk-hdUWRrsGFN0VyN8e3B96mk-X4Gc1fn2bj0RxZxmSDuBS5Usxh4TGhjtF8hd1qSKhZaaqkVZJQ0v58aDlWVGusuPeC5wZTMSRCsR5Qh7k2VilF57M6ho2J3xnB2Q539oc7O-Het1gbvT1E6-1q4_JT8Mi31e-OuknWFL6la0M62aiUlHPCfgE3uYcn</recordid><startdate>19970801</startdate><enddate>19970801</enddate><creator>CHERTOW, B. S</creator><creator>GOKING, N. Q</creator><creator>DRISCOLL, H. K</creator><creator>PRIMERANO, D. A</creator><creator>MATTHEWS, K. A</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19970801</creationdate><title>Effects of all-trans-retinoic acid (ATRA) and retinoic acid receptor (RAR) expression on secretion, growth, and apoptosis of insulin-secreting RINm5F cells</title><author>CHERTOW, B. S ; GOKING, N. Q ; DRISCOLL, H. K ; PRIMERANO, D. A ; MATTHEWS, K. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-576d883e06f012e32db0eb412ab9287c871210174c508299085ff65da02641683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Apoptosis - drug effects</topic><topic>Biological and medical sciences</topic><topic>Blotting, Northern</topic><topic>Cell Division - drug effects</topic><topic>Cell Line</topic><topic>Deoxyuracil Nucleotides - metabolism</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>DNA Nucleotidylexotransferase - metabolism</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Gene Expression</topic><topic>Glucose - pharmacology</topic><topic>Insulin - metabolism</topic><topic>Insulin Secretion</topic><topic>Islets of Langerhans - cytology</topic><topic>Islets of Langerhans - drug effects</topic><topic>Islets of Langerhans - metabolism</topic><topic>Medical sciences</topic><topic>Receptors, Retinoic Acid - genetics</topic><topic>Receptors, Retinoic Acid - physiology</topic><topic>Transfection</topic><topic>Tretinoin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHERTOW, B. S</creatorcontrib><creatorcontrib>GOKING, N. Q</creatorcontrib><creatorcontrib>DRISCOLL, H. K</creatorcontrib><creatorcontrib>PRIMERANO, D. A</creatorcontrib><creatorcontrib>MATTHEWS, K. A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Pancreas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHERTOW, B. S</au><au>GOKING, N. Q</au><au>DRISCOLL, H. K</au><au>PRIMERANO, D. A</au><au>MATTHEWS, K. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of all-trans-retinoic acid (ATRA) and retinoic acid receptor (RAR) expression on secretion, growth, and apoptosis of insulin-secreting RINm5F cells</atitle><jtitle>Pancreas</jtitle><addtitle>Pancreas</addtitle><date>1997-08-01</date><risdate>1997</risdate><volume>15</volume><issue>2</issue><spage>122</spage><epage>131</epage><pages>122-131</pages><issn>0885-3177</issn><eissn>1536-4828</eissn><coden>PANCE4</coden><abstract>To define the functions of retinoids and their receptors in insulin secretion, we tested the effects of all-trans-retinoic acid (ATRA) and retinoic acid receptor (RAR) expression on cell growth, differentiation, and secretion using insulin-secreting RINm5F cells. Wild-type cells with a low abundance of mRNA for RAR beta were transfected with RAR beta or chloramphenicol acetyltransferase (CAT control). Cells were cultured for 2-7 days in media without (A-def) or with ATRA, 1, 10, 100, and 1,000 nM. At day 2 of culture, ATRA stimulated insulin release in wild-type and transfected cells, and this effect was dose dependent. At 7 days, ATRA stimulated insulin secretion from wild-type cells twofold at glucose concentrations of 0.5 mM (A-def, 5.1 +/- 0.27; ATRA, 1,000 nM, 10.5 +/- 1.43 ng/10(6) cells) and at 11.0 mM (A-def, 6.9 +/- 0.24; ATRA, 1,000 nM, 13.6 +/- 1.86 ng/10(6) cells). The cellular insulin content was increased about threefold (A-def, 39.2 +/- 2.95; ATRA, 1,000 nM, 118 +/- 8.54 ng/10(6) cells). ATRA inhibited growth of wild-type cells as early as 3 days, and this effect was dose dependent. Whereas in the absence of ATRA, the cell number increased over fivefold between day 3 and day 5, ATRA, 1,000 nM, inhibited cell growth completely. ATRA, 1,000 nM, increased apoptotic RINm5F cells (day 3 A-def, 0.53 +/- 0.27% of total cells, and ATRA, 2.30 +/- 1.44; day 5 A-def, 0.38 +/- 0.23, and ATRA, 2.14 +/- 0.59; day 7 A-def, 0.90 +/- 0.29, and ATRA, 6.02 +/- 1.64). RAR beta-transfected cells showed overexpression of mRNA to RAR beta and dose-dependent inhibition of growth, with almost-complete inhibition at ATRA concentrations as low as 100 nM. Overexpression of RAR beta increased insulin secretion at ATRA, 100-1,000 nM. In summary, ATRA increased the insulin secretion and content of RINm5F cells, while inhibiting growth and increasing apoptosis. Increased expression of RAR beta facilitated these effects on growth and secretion. These findings may reflect the known effect of ATRA on differentiation of cells and mediation through RAR beta.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>9260196</pmid><doi>10.1097/00006676-199708000-00003</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-3177 |
ispartof | Pancreas, 1997-08, Vol.15 (2), p.122-131 |
issn | 0885-3177 1536-4828 |
language | eng |
recordid | cdi_crossref_primary_10_1097_00006676_199708000_00003 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Apoptosis - drug effects Biological and medical sciences Blotting, Northern Cell Division - drug effects Cell Line Deoxyuracil Nucleotides - metabolism Diabetes. Impaired glucose tolerance DNA Nucleotidylexotransferase - metabolism Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Gene Expression Glucose - pharmacology Insulin - metabolism Insulin Secretion Islets of Langerhans - cytology Islets of Langerhans - drug effects Islets of Langerhans - metabolism Medical sciences Receptors, Retinoic Acid - genetics Receptors, Retinoic Acid - physiology Transfection Tretinoin - pharmacology |
title | Effects of all-trans-retinoic acid (ATRA) and retinoic acid receptor (RAR) expression on secretion, growth, and apoptosis of insulin-secreting RINm5F cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T09%3A03%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20all-trans-retinoic%20acid%20(ATRA)%20and%20retinoic%20acid%20receptor%20(RAR)%20expression%20on%20secretion,%20growth,%20and%20apoptosis%20of%20insulin-secreting%20RINm5F%20cells&rft.jtitle=Pancreas&rft.au=CHERTOW,%20B.%20S&rft.date=1997-08-01&rft.volume=15&rft.issue=2&rft.spage=122&rft.epage=131&rft.pages=122-131&rft.issn=0885-3177&rft.eissn=1536-4828&rft.coden=PANCE4&rft_id=info:doi/10.1097/00006676-199708000-00003&rft_dat=%3Cpubmed_cross%3E9260196%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/9260196&rfr_iscdi=true |